Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.5380
-0.0010 (-0.19%)
At close: May 12, 2025, 4:00 PM
0.5200
-0.0180 (-3.35%)
After-hours: May 12, 2025, 6:50 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $8.17 million as of May 12, 2025. Its market cap has decreased by -85.07% in one year.
Market Cap
8.17M
Enterprise Value
5.72M
1-Year Change
-85.07%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $8.17M, a decrease of -87.63%. That is a compound annual growth rate of -67.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 8.18M | -69.22% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |